Related Experiment Videos

Assessing contemporary intensive care unit outcome: an updated Mortality Probability Admission Model (MPM0-III)

Thomas L Higgins1, Daniel Teres, Wayne S Copes

  • 1Critical Care Division, Baystate Medical Center, Springfield, MA, USA.

Critical Care Medicine
|January 27, 2007
PubMed
Abstract

Insights

The updated Mortality Probability Model (MPM0-III) uses current data to more accurately predict intensive care unit (ICU) mortality. This revised model improves risk assessment for ICU patients compared to the older MPM0-II.

Area of Science:

  • Critical Care Medicine
  • Health Services Research
  • Biostatistics

Background:

  • The Mortality Probability Model at intensive care unit (ICU) admission (MPM0-II) is a tool for predicting patient outcomes.
  • Contemporary ICU data may differ from the data used to develop the MPM0-II, potentially affecting its accuracy.
  • Updating predictive models with current data is essential for relevant clinical decision-making and resource allocation.

Purpose of the Study:

  • To update the Mortality Probability Model at ICU admission (MPM0-II) using contemporary patient data.
  • To assess the continued relevance of MPM0-II risk factors in current ICU populations.
  • To develop an improved model (MPM0-III) for predicting hospital mortality in ICU patients.

Main Methods:

  • Retrospective analysis of 124,855 patients from 135 ICUs (Project IMPACT, 2001-2004).
  • Utilized 15 MPM0-II variables, pre-ICU admission time, and code status.
  • Employed univariate and multivariate logistic regression to identify mortality risk factors.

Main Results:

  • Hospital mortality decreased from 20.8% (MPM0-II cohort) to 13.8% (current data).
  • MPM0-II variables remained significant predictors; gastrointestinal bleeding risk decreased.
  • MPM0-III incorporates 'full code' status and 'zero factor', plus age interactions, showing good calibration (SMR 1.018, AUC 0.823).

Conclusions:

  • Original MPM0-II risk factors are still relevant but the 1993 model overpredicts contemporary ICU mortality.
  • MPM0-III, with a larger dataset and new variables/interactions, offers more accurate prediction of ICU outcomes.
  • The updated model provides better comparisons of actual versus expected ICU outcomes in current practice.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: